United Therapeutics Corp (NASDAQ:UTHR)

During the Trading Day
165.96 +0.18 / +0.11%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
165.96 0.00 / 0.00%
 
Volume: 24.6K

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 175.00, with a high estimate of 225.00 and a low estimate of 95.00. The median estimate represents a +5.45% increase from the last price of 165.96.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in United Therapeutics Corp. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.31
Sales
$359.5M
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 742.29%
 
 
 
 
 
 
Growthannually 17.63%
 
 
 
 
 
 

Sales

Growthquarterly 9.77%
 
 
 
 
 
 
Growthannually 14.79%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account